ロード中...
Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
Lung cancer immunotherapy is an effective treatment option; however, it can be hampered by adverse events, including pancreatitis, associated with excessive immune activation. Here, we report the case of a 70‐year‐old patient who presented with recurrent lung squamous carcinoma and was started with...
保存先:
| 出版年: | Respirol Case Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000995/ https://ncbi.nlm.nih.gov/pubmed/32042430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.525 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|